280 related articles for article (PubMed ID: 29211350)
1. The angiotensin II receptors type 1 blockage affects the urinary bladder activity in hyperosmolar-induced detrusor overactivity in rats: Preliminary results.
Juszczak K; Maciukiewicz P
Adv Clin Exp Med; 2017 Oct; 26(7):1047-1051. PubMed ID: 29211350
[TBL] [Abstract][Full Text] [Related]
2. The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats.
Juszczak K; Maciukiewicz P
Can J Physiol Pharmacol; 2015 Aug; 93(8):721-6. PubMed ID: 26243021
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin II receptor antagonist telmisartan on detrusor overactivity in rats with bladder outlet obstruction.
Cho ST; Park EY; Kim JC
Urology; 2012 Nov; 80(5):1163.e1-7. PubMed ID: 22795377
[TBL] [Abstract][Full Text] [Related]
4. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
Juszczak K; Ziomber A; Wyczolkowski M; Thor PJ
J Physiol Pharmacol; 2009 Dec; 60(4):85-91. PubMed ID: 20065501
[TBL] [Abstract][Full Text] [Related]
5. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.
Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ
Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976
[TBL] [Abstract][Full Text] [Related]
6. Effects of the gonadotropin-releasing hormone antagonist ganirelix on normal micturition and prostaglandin E(2)-induced detrusor overactivity in conscious female rats.
Russo A; Castiglione F; Salonia A; Benigni F; Rigatti P; Montorsi F; Andersson KE; Hedlund P
Eur Urol; 2011 May; 59(5):868-74. PubMed ID: 21196074
[TBL] [Abstract][Full Text] [Related]
7. The influence of Rho-kinase inhibition on acetic acid-induced detrusor overactivity.
Wróbel A; Rechberger T
Neurourol Urodyn; 2017 Feb; 36(2):263-270. PubMed ID: 26546786
[TBL] [Abstract][Full Text] [Related]
8. The ameliorating effect of exogenous melatonin on urinary bladder function in hyperosmolar bladder overactivity and its influence on the autonomic nervous system activity.
Juszczak K; Ziomber A; Machowska A; Furgała A; Dobrek Ł; Wyczółkowski M; Thor PJ
Acta Medica (Hradec Kralove); 2011; 54(2):63-8. PubMed ID: 21842719
[TBL] [Abstract][Full Text] [Related]
9. The effect of combined treatment with a β
Wróbel A; Rechberger T
Neurourol Urodyn; 2017 Mar; 36(3):580-588. PubMed ID: 26879338
[TBL] [Abstract][Full Text] [Related]
10. A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation.
Wróbel A; Łańcut M; Rechberger T
J Pharmacol Toxicol Methods; 2015; 74():7-16. PubMed ID: 25957030
[TBL] [Abstract][Full Text] [Related]
11. Effect of partial and complete blockade of vanilloid (TRPV1-6) and ankyrin (TRPA1) transient receptor potential ion channels on urinary bladder motor activity in an experimental hyperosmolar overactive bladder rat model.
Juszczak K; Ziomber A; Thor PJ
J Physiol Pharmacol; 2011 Jun; 62(3):321-6. PubMed ID: 21893692
[TBL] [Abstract][Full Text] [Related]
12. JTS-653 blocks afferent nerve firing and attenuates bladder overactivity without affecting normal voiding function.
Kitagawa Y; Wada M; Kanehisa T; Miyai A; Usui K; Maekawa M; Sakata M; Matsuo A; Hayashi M; Matsushita M
J Urol; 2013 Mar; 189(3):1137-46. PubMed ID: 22999996
[TBL] [Abstract][Full Text] [Related]
13. The influence of Potentilla chinensis aqueous extract on urinary bladder function in retinyl acetate-induced detrusor overactivity in rats.
Wróbel A; Juszczak K; Adamowicz J; Drewa T; Dudka J
Biomed Pharmacother; 2020 Dec; 132():110861. PubMed ID: 33113423
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats.
Bakali E; Mbaki Y; Lambert DG; Elliott RA; Mason R; Tincello DG
Int Urogynecol J; 2016 Sep; 27(9):1393-400. PubMed ID: 26942594
[TBL] [Abstract][Full Text] [Related]
15. Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder.
Aikawa K; Sakai T; Ishibashi K; Shiomi H; Sagawa K; Kumagai S; Kataoka M; Akaihata H; Yamaguchi O
Int J Urol; 2012 May; 19(5):457-64. PubMed ID: 22320898
[TBL] [Abstract][Full Text] [Related]
16. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
Yokoyama O; Miwa Y; Oyama N; Aoki Y; Ito H; Akino H
J Urol; 2007 Nov; 178(5):2208-12. PubMed ID: 17870108
[TBL] [Abstract][Full Text] [Related]
17. The influence of duloxetine on detrusor overactivity in rats with depression induced by 13-cis-retinoic acid.
Wróbel A; Rechberger E; Rechberger T
Int Urogynecol J; 2018 Jul; 29(7):987-995. PubMed ID: 28762178
[TBL] [Abstract][Full Text] [Related]
18. The integrative function of vagal nerves in urinary bladder activity in rats with and without intravesical noxious stimulation.
Juszczak K; Thor PJ
Folia Med Cracov; 2012; 52(1-2):5-16. PubMed ID: 23697211
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
20. Urodynamic effects of a novel EP(1) receptor antagonist in normal rats and rats with bladder outlet obstruction.
Lee T; Hedlund P; Newgreen D; Andersson KE
J Urol; 2007 Apr; 177(4):1562-7. PubMed ID: 17382779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
